13F
中

ZBH ZIMMER BIOMET HOLDINGS INC

2026Q1 · CUSIP 98956P102 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
903
Δ holders QoQ
-35
Breadth percentile
Top 96%
Whale holders
278
Δ whales
-5
Inst. holding value
$17.3B
New positions
95
Closed positions
130
Price momentum (1Q)
-12.1%
Put / Call
10/6

Breadth history (34 quarters)

2018Q1: Δ+12 · h=847 2018Q2: Δ-8 · h=839 2018Q3: Δ+16 · h=855 2018Q4: Δ-11 · h=844 2019Q1: Δ+27 · h=871 2019Q2: Δ-19 · h=852 2019Q3: Δ+21 · h=873 2019Q4: Δ+85 · h=958 2020Q1: Δ-99 · h=859 2020Q2: Δ+57 · h=916 2020Q3: Δ-19 · h=897 2020Q4: Δ+87 · h=984 2021Q1: Δ+14 · h=998 2021Q2: Δ-11 · h=987 2021Q3: Δ-28 · h=959 2021Q4: Δ+18 · h=977 2022Q1: Δ-16 · h=961 2022Q2: Δ-19 · h=942 2022Q3: Δ-38 · h=904 2022Q4: Δ+58 · h=962 2023Q1: Δ+21 · h=983 2023Q2: Δ+36 · h=1019 2023Q3: Δ-15 · h=1004 2023Q4: Δ+15 · h=1019 2024Q1: Δ-17 · h=1002 2024Q2: Δ-9 · h=993 2024Q3: Δ-21 · h=972 2024Q4: Δ+46 · h=1018 2025Q1: Δ-26 · h=992 2025Q2: Δ-63 · h=929 2025Q3: Δ+27 · h=956 2025Q4: Δ-18 · h=938 2026Q1: Δ-35 · h=903 2018Q1: holders=847 2018Q2: holders=839 2018Q3: holders=855 2018Q4: holders=844 2019Q1: holders=871 2019Q2: holders=852 2019Q3: holders=873 2019Q4: holders=958 2020Q1: holders=859 2020Q2: holders=916 2020Q3: holders=897 2020Q4: holders=984 2021Q1: holders=998 2021Q2: holders=987 2021Q3: holders=959 2021Q4: holders=977 2022Q1: holders=961 2022Q2: holders=942 2022Q3: holders=904 2022Q4: holders=962 2023Q1: holders=983 2023Q2: holders=1019 2023Q3: holders=1004 2023Q4: holders=1019 2024Q1: holders=1002 2024Q2: holders=993 2024Q3: holders=972 2024Q4: holders=1018 2025Q1: holders=992 2025Q2: holders=929 2025Q3: holders=956 2025Q4: holders=938 2026Q1: holders=903 -99 -49.5 +0 +49.5 +99 7559131070 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 12 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 11% +12.3% -3.2%
2024Q4 Top 10% -6.1% +2.6%
2023Q2 Top 4% -10.5% +3.3%
2023Q1 Top 7% -10.9% -17.4%
2022Q4 Top 6% +8.1% -4.4%
2020Q4 Top 6% +3.5% -8.3%
2020Q2 Top 4% +9.4% +14.8%
2019Q4 Top 4% -22.8% -12.6%

Options Sentiment

Put holders
10
QoQ: -1
Call holders
6
QoQ: -5

See methodology →

Fundamentals

PE (TTM)
23.2
EPS (TTM)
$3.86
EPS YoY
-14.2%
Revenue (TTM)
$8.4B
Revenue YoY
+9.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1.8B 2022-09-30: $1.7B 2022-12-31: $1.8B 2023-03-31: $1.8B 2023-06-30: $1.9B 2023-09-30: $1.8B 2023-12-31: $1.9B 2024-03-31: $1.9B 2024-06-30: $1.9B 2024-09-30: $1.8B 2024-12-31: $2.0B 2025-03-31: $1.9B 2025-06-30: $2.1B 2025-09-30: $2.0B 2025-12-31: $2.2B 2026-03-31: $2.1B 2022-06-30: EPS 0.73 2022-09-30: EPS 0.92 2022-12-31: EPS -0.62 2023-03-31: EPS 1.11 2023-06-30: EPS 1.00 2023-09-30: EPS 0.77 2023-12-31: EPS 2.00 2024-03-31: EPS 0.84 2024-06-30: EPS 1.18 2024-09-30: EPS 1.23 2024-12-31: EPS 1.18 2025-03-31: EPS 0.91 2025-06-30: EPS 0.77 2025-09-30: EPS 1.16 2025-12-31: EPS 0.71 2026-03-31: EPS 1.22 0B 1.1B 2.2B $B -0.68 0.76 2.20 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 25 2023-03-31: PE 60.92023-06-30: PE 48.82023-09-30: PE 48.12023-12-31: PE 252024-03-31: PE 25.52024-06-30: PE 22.72024-09-30: PE 21.12024-12-31: PE 22.32025-03-31: PE 21.32025-06-30: PE 24.92025-09-30: PE 22.22025-12-31: PE 272026-03-31: PE 21.6 19 41 64 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)